- Home
- VRNA vs HBI Comparison
VRNA vs HBI Comparison
Compare VRNA & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRNA
- HBI
- Stock Information
- Founded
- VRNA 2005
- HBI 1901
- Country
- VRNA United Kingdom
- HBI United States
- Employees
- VRNA N/A
- HBI N/A
- Industry
- VRNA Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- VRNA Health Care
- HBI Consumer Discretionary
- Exchange
- VRNA Nasdaq
- HBI Nasdaq
- Market Cap
- VRNA 3.4B
- HBI 2.9B
- IPO Year
- VRNA 2017
- HBI 2006
- Fundamental
- Price
- VRNA $51.89
- HBI $8.29
- Analyst Decision
- VRNA Strong Buy
- HBI Hold
- Analyst Count
- VRNA 7
- HBI 5
- Target Price
- VRNA $50.57
- HBI $6.90
- AVG Volume (30 Days)
- VRNA 1.4M
- HBI 5.2M
- Earning Date
- VRNA 02-27-2025
- HBI 02-13-2025
- Dividend Yield
- VRNA N/A
- HBI N/A
- EPS Growth
- VRNA N/A
- HBI N/A
- EPS
- VRNA N/A
- HBI N/A
- Revenue
- VRNA $5,624,000.00
- HBI $5,466,904,000.00
- Revenue This Year
- VRNA N/A
- HBI N/A
- Revenue Next Year
- VRNA $550.30
- HBI $1.54
- P/E Ratio
- VRNA N/A
- HBI N/A
- Revenue Growth
- VRNA 1127.95
- HBI 25.57
- 52 Week Low
- VRNA $11.39
- HBI $3.88
- 52 Week High
- VRNA $55.42
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- VRNA 64.25
- HBI 49.59
- Support Level
- VRNA $43.44
- HBI $8.24
- Resistance Level
- VRNA $55.42
- HBI $8.84
- Average True Range (ATR)
- VRNA 3.32
- HBI 0.27
- MACD
- VRNA 0.40
- HBI 0.00
- Stochastic Oscillator
- VRNA 70.52
- HBI 43.88
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated as it produces more than 70% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina.